Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Person › Details

Peter Coleman (Cobra Biologics Holding AB)

Coleman, Peter (Cobra Biologics 201106 CEO– before RecipharmCobra Biologics)


Organisation Organisation Cobra Biologics Holding AB
  Group Cobra Biologics (Group)
Products Product pharmaceutical
  Product 2 contract manufacturing (drugs)

Recipharm AB. (6/30/11). "Press Release: Cobra Biologics Holding AB Acquires Recipharm AB’s Shares in RecipharmCobra Biologics".

Recipharm AB and Cobra Biologics Holding AB are pleased to announce that they have today completed a transaction whereby Cobra Biologics Holding AB has acquired Recipharm AB’s shares in the operating companies of RecipharmCobra Biologics located in Keele, UK and Södertälje, Sweden.

Cobra Biologics Holding AB is the new company formed for the purposes of developing this business further. The shareholders in the new company will be made up of the Management Team, Zentricity Holding AB and Recipharm AB.

Thomas Eldered, CEO of Recipharm AB commented “Following a strategic review we have decided to concentrate resources on our core business of pharmaceutical development and commercial manufacturing services for the time being. In the long term we still believe the contract development of biologics is an extremely important business and this transaction will allow us to both retain a stake in and maintain close links with Cobra Biologics. They will continue to be an important partner in this sector and we wish the team every success for the future”.

Peter Coleman, who was previously General Manager of RecipharmCobra Biologics will become the CEO of Cobra Biologics Holding AB. He commented “Our new shareholders allow us to remain financially stable whilst focusing on our core business of biologics contract development and manufacturing. We also have the added advantage of continuing our relationship with Recipharm AB”.

Cobra Biologics Holding AB will continue to trade as RecipharmCobra Biologics.

Record changed: 2020-03-28


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Peter Coleman

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top